Effects of preoperative psoas muscle index and body mass index on postoperative outcomes after video‐assisted esophagectomy for esophageal cancer

Preoperative psoas muscle index (PMI) and body mass index (BMI) are relevant to postoperative outcomes. We investigated the associations of PMI, BMI, and preoperative nutritional and muscular score with postoperative outcomes in patients with esophageal cancer who underwent video‐assisted surgery.

[1]  Ken Kato,et al.  Immuno-oncology for esophageal cancer. , 2020, Future oncology.

[2]  S. Ozawa,et al.  Prognostic significance of sarcopenia in patients undergoing esophagectomy for superficial esophageal squamous cell carcinoma. , 2019, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[3]  T. Shichinohe,et al.  Impact of Preoperative Skeletal Muscle Mass and Nutritional Status on Short-and Long-Term Outcomes After Esophagectomy for Esophageal Cancer: A Retrospective Observational Study , 2019, Annals of Surgical Oncology.

[4]  H. Deng,et al.  Preoperative sarcopenia is a predictor of poor prognosis of esophageal cancer after esophagectomy: a comprehensive systematic review and meta-analysis. , 2018, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[5]  N. Kokudo,et al.  Sarcopenia, the depletion of muscle mass, an independent predictor of respiratory complications after oncological esophagectomy. , 2018, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[6]  V. Baracos,et al.  Assessment of body composition and sarcopenia in patients with esophageal cancer: a systematic review and meta-analysis. , 2018, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[7]  M. Yao,et al.  A low psoas muscle volume predicts longer hospitalization and cancer recurrence in upper urinary tract urothelial carcinoma. , 2017, Molecular and clinical oncology.

[8]  M. Yao,et al.  A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy , 2017, BioMed research international.

[9]  S. Motoyama,et al.  Decreased Skeletal Muscle Mass After Neoadjuvant Therapy Correlates with Poor Prognosis in Patients with Esophageal Cancer. , 2016, Anticancer research.

[10]  S. Uemoto,et al.  Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults. , 2016, Nutrition.

[11]  S. Tsunoda,et al.  Sarcopenia as a predictor of pulmonary complications after esophagectomy for thoracic esophageal cancer , 2016, Journal of surgical oncology.

[12]  L. Peng,et al.  Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. , 2014, Journal of the American Medical Directors Association.

[13]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[14]  S. Kondo,et al.  Minimally invasive esophagectomy for cancer patients with low pulmonary function. , 2010, Hepato-Gastroenterology.

[15]  I. Tabata,et al.  A cross-sectional study of sarcopenia in Japanese men and women: reference values and association with cardiovascular risk factors , 2010, European Journal of Applied Physiology.

[16]  S. Kondo,et al.  Video-assisted esophagectomy for esophageal cancer , 2008, Surgery Today.

[17]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[18]  Toshio Shimizu,et al.  [Common toxicity criteria: version 2.0, an improved reference for grading the adverse reaction of cancer treatment]. , 2003, Nihon rinsho. Japanese journal of clinical medicine.

[19]  S. Okushiba,et al.  Hand-Assisted Endoscopic Esophagectomy for Esophageal Cancer , 2003, Surgery Today.